Comprehensive Review on Plant-Derived Antifungals: Nigella sativa and Catharanthus roseus Against Opportunistic Candida Infections

Fungal infections caused by Candida species represent a critical global healthcare challenge due to the rising prevalence of immunocompromised host conditions and increasing resistance to conventional antifungal agents. Synthetic therapies—including azoles, echinocandins, and polyenes—are frequently limited by host toxicity, adverse drug interactions, high costs, and the rapid emergence of multidrug-resistant strains like Candida auris. Consequently, plant-based secondary metabolites have gained attention as alternative or synergistic therapeutic agents. This review provides a comprehensive synthesis of the pathogenic burden of candidiasis, mechanisms of current antifungal classes, and the therapeutic efficacy of Nigella sativa Linn. and Catharanthus roseus Linn. Active constituents such as thymoquinone (N. sativa) and indole alkaloids (C. roseus) demonstrate distinct multi-target antimicrobial mechanisms. Pharmacological evaluation highlights the superior antifungal potency of N. sativa extracts over C. roseus against various clinical Candida strains. Furthermore, current research gaps, standardization challenges, and future clinical integration strategies are critically evaluated.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414657
Primary Topic
Nigella sativa pharmacological applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comprehensive Review on Plant-Derived Antifungals: Nigella sativa and Catharanthus roseus Against Opportunistic Candida Infections

Rajesh Asija, Richa Agarwal, Najrana
Zenodo (CERN European Organization for Nuclear Research)
Nigella sativa pharmacological applications
article

Comprehensive Review on Plant-Derived Antifungals: Nigella sativa and Catharanthus roseus Against Opportunistic Candida Infections

Rajesh Asija, Richa Agarwal, Najrana
article en

Abstract

Fungal infections caused by Candida species represent a critical global healthcare challenge due to the rising prevalence of immunocompromised host conditions and increasing resistance to conventional antifungal agents. Synthetic therapies—including azoles, echinocandins, and polyenes—are frequently limited by host toxicity, adverse drug interactions, high costs, and the rapid emergence of multidrug-resistant strains like Candida auris. Consequently, plant-based secondary metabolites have gained attention as alternative or synergistic therapeutic agents. This review provides a comprehensive synthesis of the pathogenic burden of candidiasis, mechanisms of current antifungal classes, and the therapeutic efficacy of Nigella sativa Linn. and Catharanthus roseus Linn. Active constituents such as thymoquinone (N. sativa) and indole alkaloids (C. roseus) demonstrate distinct multi-target antimicrobial mechanisms. Pharmacological evaluation highlights the superior antifungal potency of N. sativa extracts over C. roseus against various clinical Candida strains. Furthermore, current research gaps, standardization challenges, and future clinical integration strategies are critically evaluated.

Zenodo (CERN European Organization for Nuclear Research)
Nigella sativa pharmacological applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon